Michael R Hayden Selected Research

Michael R Hayden Research Topics

Disease

137	Huntington Disease (Huntington's Disease) 02/2024 - 02/2002
47	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024 - 05/2004
15	Atherosclerosis 11/2017 - 01/2002
11	Disease Progression 02/2024 - 11/2002
11	Neoplasms (Cancer) 01/2022 - 01/2011
11	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 05/2004
10	Inflammation (Inflammations) 01/2023 - 03/2009
9	Tangier Disease 01/2015 - 10/2002
9	Hypertriglyceridemia 01/2011 - 11/2002
8	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 02/2006
8	Atrophy 06/2019 - 04/2002
8	Drug-Related Side Effects and Adverse Reactions 01/2018 - 09/2007
8	Type 2 Diabetes Mellitus (MODY) 01/2016 - 03/2007
7	Insulin Resistance 11/2022 - 01/2008
7	Multiple Sclerosis 11/2017 - 05/2015
7	Cardiotoxicity 01/2017 - 09/2011
5	Cognitive Dysfunction 10/2018 - 04/2005
5	Hypoalphalipoproteinemias (Hypoalphalipoproteinemia) 08/2006 - 10/2002
4	Gliosis 05/2023 - 06/2013
4	Glucose Intolerance 01/2016 - 01/2010
4	Cardiovascular Diseases (Cardiovascular Disease) 04/2015 - 01/2002
4	Coronary Artery Disease (Coronary Atherosclerosis) 03/2012 - 10/2004
4	Pancreatitis 02/2009 - 09/2004
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 04/2023 - 12/2016
3	Neuroinflammatory Diseases 01/2023 - 06/2013
3	Parkinson Disease (Parkinson's Disease) 01/2019 - 01/2016
3	Ototoxicity 01/2018 - 12/2009
3	Body Weight (Weight, Body) 04/2015 - 04/2010
3	Obesity 03/2014 - 03/2009
3	Hyperlipidemias (Hyperlipidemia) 08/2009 - 11/2002
3	Juvenile Amyotrophic Lateral Sclerosis 2 01/2007 - 12/2003
2	Seizures (Absence Seizure) 05/2023 - 10/2010
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2023 - 02/2010
2	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 01/2023 - 05/2006
2	Parkinsonian Disorders (Parkinsonism) 01/2019 - 01/2019
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2019 - 01/2015
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2018 - 12/2009
2	Hearing Loss (Hearing Impairment) 01/2018 - 12/2009
2	Testicular Neoplasms (Testicular Cancer) 01/2018 - 11/2017

Drug/Important Bio-Agent (IBA)

46	polyglutamineIBA 01/2023 - 02/2002
39	Proteins (Proteins, Gene)FDA Link 01/2024 - 02/2002
21	CholesterolIBA 04/2021 - 01/2002
18	Huntingtin ProteinIBA 01/2023 - 08/2002
14	Caspase 6IBA 10/2020 - 01/2011
13	HDL CholesterolIBA 04/2015 - 11/2004
11	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019 - 03/2002
9	pridopidineIBA 04/2023 - 01/2016
9	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2023 - 09/2004
9	LipidsIBA 01/2018 - 08/2003
9	Triglycerides (Triacylglycerol)IBA 03/2014 - 11/2002
7	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 07/2002
7	CaspasesIBA 01/2018 - 09/2002
7	AnthracyclinesIBA 01/2017 - 09/2011
6	Antisense OligonucleotidesIBA 01/2024 - 12/2011
6	Sigma-1 ReceptorIBA 04/2023 - 01/2019
6	laquinimodIBA 01/2023 - 01/2016
6	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 01/2008
6	Insulin (Novolin)FDA Link 11/2022 - 01/2008
6	ATP-Binding Cassette Transporters (ABC Transporters)IBA 03/2012 - 06/2003
5	Brain-Derived Neurotrophic Factor (BDNF)IBA 05/2023 - 11/2010
5	Apolipoproteins E (ApoE)IBA 01/2022 - 12/2005
5	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 12/2009
5	Amyloid (Amyloid Fibrils)IBA 01/2017 - 12/2005
5	Mutant Proteins (Protein, Mutant)IBA 01/2014 - 08/2002
5	Opioid Analgesics (Opioids)IBA 05/2013 - 10/2010
4	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2024 - 10/2004
4	Steroid 12-alpha-Hydroxylase (CYP8B1)IBA 11/2022 - 04/2015
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2005
4	LDL Receptors (LDL Receptor)IBA 10/2019 - 04/2006
4	HDL LipoproteinsIBA 11/2017 - 10/2005
4	Glatiramer Acetate (Copaxone)FDA Link 11/2017 - 05/2015
4	CalciumIBA 01/2016 - 08/2002
4	Codeine (Codeine Phosphate)FDA LinkGeneric 01/2013 - 08/2011
4	Lipoproteins (Lipoprotein)IBA 01/2011 - 02/2008
4	Adenosine Triphosphate (ATP)IBA 02/2010 - 10/2002
3	Bile Acids and Salts (Bile Acids)IBA 11/2022 - 01/2018
3	Neuroprotective AgentsIBA 11/2021 - 12/2012
3	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 10/2005
3	Peptides (Polypeptides)IBA 11/2017 - 01/2012
3	Insulin-Like Growth Factor I (IGF-1)IBA 08/2016 - 04/2010
3	Monoamine Oxidase (MAO)IBA 04/2016 - 12/2015
3	Warfarin (Coumadin)FDA LinkGeneric 06/2014 - 09/2011
3	TransferasesIBA 11/2013 - 12/2009
3	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 12/2012 - 08/2011
3	stearoyl-coenzyme A (stearoyl-CoA)IBA 12/2009 - 01/2008
3	N-Methylaspartate (NMDA)IBA 09/2009 - 02/2007
2	Glutamic Acid (Glutamate)FDA Link 01/2023 - 10/2010
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 01/2016
2	Cholic AcidIBA 11/2022 - 01/2018
2	Complement System Proteins (Complement)IBA 01/2022 - 01/2020
2	MicroRNAs (MicroRNA)IBA 10/2020 - 03/2016
2	Vincristine (Oncovin)FDA LinkGeneric 01/2019 - 04/2013
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2018 - 02/2014
2	Histone Deacetylase InhibitorsIBA 01/2017 - 10/2006
2	CytokinesIBA 01/2016 - 05/2004
2	Genetic Markers (Genetic Marker)IBA 01/2016 - 09/2010
2	ATP Binding Cassette Transporter 1IBA 01/2016 - 05/2005

Therapy/Procedure

19	Therapeutics 01/2023 - 04/2005
3	Immunotherapy 02/2024 - 04/2015
3	Drug Therapy (Chemotherapy) 11/2017 - 12/2009